TRANSCODE THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.63
-5.78%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+5.5%
3 months
-61.4%
6 months
-79.2%
1 year
-85.1%
Year to date
-76.1%
52-week range
$1.55 – $12.34
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$27.6M
P/E
-0.6
P/B
-1
P/S
—
Revenue
$0
Net income
-$42.83M
Diluted EPS
-52.37
Gross margin
—
Net margin
—
Return on equity
1261.00%
Total debt
$652.41K
Cash
$8.38M
Free cash flow
-$22.61M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$6.75M | — | — | -$5.4M |
| Mar 31, 2026 | $0 | -$17.79M | — | — | -$4.98M |
| Dec 31, 2025 | $0 | -$13.44M | — | — | -$8.15M |
| Sep 30, 2025 | $0 | -$4.86M | — | — | -$4.08M |
| Jun 30, 2025 | $0 | -$4.28M | — | — | -$4.19M |
| Mar 31, 2025 | $0 | -$12.09M | — | — | -$3.1M |
| Dec 31, 2024 | $0 | -$5.92M | — | — | -$3.15M |
| Sep 30, 2024 | $0 | -$2.32M | — | — | -$3.93M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent RNAZ news
All market newsNo ticker-linked stories are in the current archive.